Tag: #UterineFibroids
-
Transforming Fibroid Care Surgical Insights from the Teaching Hospital of Angré
Introduction Uterine fibroids benign tumors affecting millions of women globally—are a major concern in gynecology. A recent study from the Teaching Hospital of Angré, Côte d’Ivoire, offers valuable perspectives on surgical management practices based on 193 cases, aligning with FIGO guidelines. Visit Obstetric and Gynecology Journal for more groundbreaking research in this field. Study Overview…
-
Unveiling Intravenous Leiomyomatosis A Rare Yet Critical Uterine Condition
Introduction Intravenous leiomyomatosis (IVL) is an uncommon but potentially life threatening uterine tumor that grows within blood vessels. Although benign, it demands immediate attention due to its aggressive spread through venous systems. Visit https://www.obstetricgynecoljournal.com for more groundbreaking research in women’s health. In this article, we delve into a recent case of IVL identified during pathological…
-
Transradial Embolization A Safer Path for Treating Uterine Fibroids in Saudi Arabia
Introduction In the evolving field of minimally invasive gynecology, transradial uterine artery embolization (UAE) is emerging as a game-changer in the treatment of symptomatic fibroids. Unlike traditional surgical methods, this technique offers a safer, quicker, and highly effective option with fewer complications.Visit https://www.obstetricgynecoljournal.com for more groundbreaking research in obstetrics and gynecology. Safety and Success of…
-
Reimagining Uterine Fibroid Care How UFE Proved Essential During the COVID 19 Pandemic
Introduction As the COVID-19 pandemic disrupted elective procedures across healthcare systems, many women living with uterine fibroids faced uncertain delays in care. In this context, the editorial “Uterine Fibroid Embolization in Time of Covid-19” by Dr. Nestor Kisilevzky and Dr. John C. Lipman highlights how Uterine Fibroid Embolization (UFE), a minimally invasive treatment, remained a…
Heighten Science Publications Inc. 